Supplements and Featured Publications
New and Emerging Therapies in the Treatment of Type 2 Diabetes
Volume: 3
Issue: 10 Suppl
Cost-Effective Treatment of Rhinitis: A Managed Care Perspective
Volume: 3
Issue: 9 Suppl
The Treatment of Hypercholesterolemia: A Managed Care Perspective
Volume: 3
Issue: 8 Suppl
Alternative Treatments for GERD: Cost and Quality Effects
Volume: 3
Issue: 7 Suppl
Inflammatory Bowel Disease: A Managed Care Perspective
Volume: 3
Issue: 6 Suppl
Global Health Economics Research: Advanced Concepts and Use in the Marketplace
Volume: 3
Issue: 5 Suppl
Prevention of Acute Myocardial Infarction and Start-to-Finish Treatment: A Managed Care Perspective
Volume: 3
Issue: 4 Suppl
Integrating Risk Factor Management of Coronary Heart Disease into Managed Care
Volume: 3
Issue: 3 Suppl
Looking Beyond the Formulary Budget: Cost Analysis and a Psychiatric Perspective
Volume: 3
Issue: 2 Suppl
Managing Hypercholesterolemia and Coronary Heart Disease
Volume: 3
Issue: 1 Suppl
Advertisement
Advertisement
Trending on AJMC
1
Survodutide Phase 3 Data Signal Metabolic Gains Beyond Weight Loss
2
Measles Cases Climb to 2000 in the US, Increasing Cases Year Over Year
3
Emerging Data Suggest Survodutide Targets Liver Fat More Rapidly Than Weight Loss: Lee Kaplan, MD, PhD
4
Survodutide Normalizes Liver Fat in 61% of Patients With MASLD in Phase 3 Trial: Lee Kaplan, MD, PhD
5